Table 3. Properties of the three causative sites identified by BSA-seq and confirmed by single site mutagenesis.
Mutant | Mutation Position | Mutation Type | Phenotypic Effect | Sequencing Depthd | Mutation Frequency | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Chr. | Position | Gene | DNA | Protein | Meana | Std Devb | Sel Coefc | Low Bulk | High Bulk | Low Bulk | High Bulk | |
YPW89 | IV | 1347028 | SSN2 | C→T | Q971Stop | +10.16% | −6.66% | 0.140 | 121 | 83 | 0 | 0.22 |
YPW94 | III | 260366 | TUP1 | G→A | G696D | +6.93% | −14.39% | 0.045 | 152 | 73 | 0 | 0.55 |
YPW102 | XVI | 679727 | ROX1 | G→A | R12K | −4.05% | −8.89% | 0.015 | 102 | 77 | 0.96 | 0.30 |
BSA-seq, bulk segregant analysis coupled with high-throughput sequencing; Chr., chromosome.
Mean expression of single site mutant relative to wild type expressed as a percentage of change in fluorescence phenotype relative to wild type.
Standard deviation of expression phenotype of the single site mutant strain relative to the reference strain.
Selection coefficient was measured by using competitive growth of each single site mutant against the control population, as described in the Materials and Methods.
Number of sequencing reads overlapping the variable site in each bulk.